Prevention of β-amyloid-induced toxicity in a differentiated neuronal (IMR32) cell line by Khaya grandifololia (Welw) C. DC.

Ella Fils Armand, Manjula Shantaram, Simon Ngamli Fewou, Frédéric Nico Njayou, Sayali Chandrashekhar Deolankar, Prashant Kumar Modi, Paul Fewou Moundipa



Alzheimer’s disease (AD) belongs to the class of neurodegenerative disorder and is biochemically characterized by amyloid-β (Aβ) plaques deposition, accumulation of neurofibrillary tangles (NFTs) accumulation and ultimately neuronal loss. Even though, the progress made in developing efficient AD therapy, there is no effective drug capable to stop and/or slow down AD progression. In the current article, we investigated the neuroprotective effect of Khaya grandifololia crude extract and fraction 2 against Aβ42-induced cytotoxicity and hyperphosphorylation of tau protein in differentiated neuronal cells (IMR32).

Reactive oxygen species production, apoptosis and mitochondrial dynamics and function, synaptic protein, and tau phosphorylation were evaluated using fluorescence microscopy and immunoblotting. Cell viability was assessed using the MTT assay.

Findings revealed that exposure of differentiated IMR32 cells to Aβ42 alone induced the impairment of mitochondrial dynamics, decrease synaptic protein expression and increase hyperphosphorylation of tau protein (phospho tau181). In contrast, the presence of crude extract and KGf2 significantly inhibited the cleavage of Caspase-3 activation. In addition, the levels of synaptic proteins (Symptosomal associated protein 25 and Synaptosin) and superoxide dismutase were restored upon treatment with crude extract and fraction 2. Hyperphosphorylation of tau protein (Thr181) and ERK (Thr202/Tyr205) activities were also significantly reduced after treatment with crude extract and fraction 2.

Our findings suggest that KG extract is a potential source for candidate drug against AD and may contribute to the development of efficient therapeutic strategy against AD.


Alzheimer’s disease; Khaya grandifololia; neuroprotection; tau protein; Amyloid β1-42


[1]. Li K, Wei Q, Liu F-F, Hu F, Xie A, Zhu L-Q, Liu D. Synaptic Dysfunction in Alzheimer’s disease: Aβ, Tau, and Epigenetic Alterations. Mol.Neurobiol. 2017;55(4):3021–3032.

[2]. Francis PT, Palmer AM, Snape M, Wilcock GK. The cholinergic hypothesis of Alzheimer’s disease: A review of progress. J Neurol Neurosurg Psychiatry. 1999;66:137–147.

[3]. Ma W-W, Tao Y, Wang Y-Y, Peng I-F. Effects of Gardenia jasminoides extracts on cognition and innate immune response in an adult Drosophila model of Alzheimer’s disease. Chin J Nat Medicines. 2017;15(12):899–904.

[4]. Zhifeng Z, Han J, Zhang J, Xiao Q, Hu J, Chen L. Pharmacological activities, mechanisms of action, and safety of salidroside in the central nervous system. Drug Des Dev Ther. 2018;12:1479–1489.

[5]. Poirier Y, Grimm A, Schmitt K, Eckert A. Link between the unfolded protein response and dysregulation of mitochondrial bioenergetics in Alzheimer’s disease. Cell Mol Life Sci. 2019;76:1419–1431.

[6]. Xia W, Li D-W, Xiang L, Chang J-J, Xia Z-L, Han E-J. Neuroprotective effects of an aqueous extract of Futokadsura stem in an Aβ-Induced Alzheimer’s disease-like rat model. Chin. J. Physiol. 2015;58(2):104–113.

[7]. Burns A, Iliffe S. "Alzheimer's disease". BMJ. 200;338:b158. https://doi: 10.1136/bmj.b1349.

[8]. Mroczko B, Groblewska M, Litman-Zawadzka A, Kornhuber J, Lewczuk P. Amyloid β oligomers (AβOs) in Alzheimer’s disease. J Neural Transm. 2018;125:177–191.

[9]. Kuca K, Soukup O, Maresova P, Korabecny J, Nepovimova E, Klimova B, et al., Current Approaches Against Alzheimer’s disease in Clinical Trials. J Braz Chem Soc. 2016;27(4):641–649.

[10]. Clark CM, Karlawish JH. Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies. Ann Intern Med. 2003;138:400–410.

[11]. Andrade S, Ramalho MJ, Loureiro JM, do Carmo Pereira M. Natural compounds for Alzheimer’s disease therapy: A systematic review of preclinical and clinical studies. Int J Mol Sci. 2019;20(9):2313. http://doi: 10.3390/ijms20092313.

[12]. L. Wang, G.F. Jin, H.H. Yu, X.H. Lu, Z.H. Zou, J.Q. Liang, et al., Protective effects of tenuifolin isolated from Polygala tenuifolia Willd roots on neuronal apoptosis and learning and memory deficits in mice with Alzheimer’s disease. Food Funct. 2019;10:7453–7460.

[13]. Ebrahimi A, Schluesener H. Natural polyphenols against neurodegenerative disorders: Potentials and pitfalls. Ageing Res Rev. 2012;11(2):329–345.

[14]. Ijarotimi SO, Agbedahunsi JM, Onyeji CO, Adewunmi CO. Chemotherapeutic interaction between Khaya grandifoliola (Welw) CDC stem bark extract and two anti-malarial drugs in mice. Afr J Tradit Complement Altern Med. 2010;7(4):370–376.

[15]. Hashem FA, Aboutabl EA, El Souda SS, Moharam M, Maamoum AA, Shabana M. Desmutagenic and antimutagenic potential of phenolics from Khaya grandifoliola (C.DC.) Meliaceae. Egypt Pharm J. 2013;12:148–154.

[16]. Njayou FN, Amougou AM, Tsayem FR, Manjia NJ, Rudraiah S, Bradley B, Manautou JE, Moundipa FP. Antioxidant fractions of Khaya grandifoliola C.DC. and Entada Africana Guill. et Perr. induce nuclear translocation of Nrf2 in HC-04 cells. Cell Stress Chaperones. 2015;20:991–1000.

[17]. Kouam AF, Yuan F, Njayou FN, He H, Tsayem RF, Oladejo BO, Song F, Moundipa PF, Gao GF. Induction of Mkp-1 and nuclear translocation of Nrf2 by limonoids from Khaya grandifoliola C.DC protect L-02 Hepatocytes against acetaminophen-induced hepatotoxicity. Front Pharmacol. 2017;8:653. https://doi: 10.3389/fphar.2017.00653.

[18]. Modi PK, Komaravelli N, Singh N, Sharma P. Interplay between MEK-ERK signaling, cyclin D1, and cyclin-dependent kinase 5 regulates cell cycle reentry and apoptosis of neurons. Mol Biol Cell. 2012;23:3722–3730.

[19]. Jahn H., Memory loss in Alzheimer's disease. Dialogues Clin Neurosci. 2013;15(4):445–454.

[20]. Forner S, Baglietto-Vargas D, Martini AC, Trujillo-Estrada L, LaFerla FM. Synaptic impairment in Alzheimer’s disease: A dysregulated symphony. Trends Neurosci. 2017;40(6):347–357.

[21]. Ali T, Yoon GH, Shah SA, Lee HY, Kim MO. Osmotin attenuates amyloid beta induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus. Scientific Reports. 2015;5:11708. https://doi: 10.1038/srep11708.

[22]. Kim A, Nam YJ, Lee MS, Shin YK, Sohn DS, Lee CS. Apigenin reduces proteasome inhibition-induced neuronal apoptosis by suppressing the cell death process. Neurochem Res. 2016;41(11):2969-2980.

[23]. Zhuang J, Li Y, Chi Y. Role of p38 MAPK activation and mitochondrial cytochrome-c release in allicin-induced apoptosis in SK-N-SH cells. Anti-Cancer Drugs. 2016;27:312–317.

[24]. Wang Z, Lin D, Zhang L, Liu W, Tan H, Ma J. Penehyclidine hydrochloride prevents anoxia/reoxygenation injury and induces H9c2 cardiomyocyte apoptosis via a mitochondrial pathway. Eur J Pharmacol. 2017;797:115–123.

[25]. Chen Z, Tao S, Li X, Zeng X, Zhang M, Yao Q. Anagliptin protects neuronal cells against endogenous amyloid β (Aβ)-induced cytotoxicity and apoptosis. Artif Cell Nanomed B. 2019;47(1):2213–2220.

[26]. Reddy PH, Manczak M, Yin X, Grady MC, Mitchell A, Kandimalla R, Kuruva CS. Protective effects of a natural product, curcumin, against amyloid β induced mitochondrial and synaptic toxicities in Alzheimer’s disease. J Investig Med 2016;64:1220–1234.

[27]. Daneshmand P, Saliminejad K, Shasaltaneh MD, Riazi GH, Nazari R, Azimzadeh P, Kamali K, Khorshid HRK. Neuroprotective effects of herbal extract (Rosa canina, Tanacetum vulgare and Urtica dioica) on rat model of sporadic Alzheimer’s disease. Avicenna J Med Biotech. 2016;8(3):120–125.

[28]. Adwan L, Subaiea GM, Basha R, Zawia NH. Tolfenamic acid reduces Tau and CDK5 Levels: implications for Dementia and Tauopathies. J Neurochem 2015;133(2):266–272.

[29]. Cao F, Wang Y, Peng B, Zhang X, Zhang D, Xu L. Effects of celastrol on Tau hyperphosphorylation and expression of HSF-1 and HSP70 in SH-SY5Y neuroblastoma cells induced by amyloid-ß peptides. Biotechnol Appl Biochem 2018;65(3):390–396.

[30]. Yao Y, Wang Y, Chen Y, Yang J. Osthole decreases tau protein phosphorylation via PI3K/AKT/GSK-3β signaling pathway in Alzheimer’s disease. Life Sci. 2019;15(217):16–24.

[31]. Jhang KA, Park J-S, Kim H-S, Chong YH. Resveratrol ameliorates tau hyperphosphorylation at Ser396 site and oxidative damage in rat hippocampal slices exposed to vanadate: Implication of ERK1/2 and GSK-3β signaling cascades. J Agric Food Chem. 2017;64(44):9626–9634.

[32]. Sereia AL, de Oliveira MT, Baranoski A, Marques LLM, Ribeiro FM, Isolani RG, de Medeiros DC, Chierrito D, Lazarin-Bidoia D, Zielinski AAF, Novello CR, Nakamura CV, Mantovani MS, de Mello JCP. In vitro evaluation of the protective effects of plant extracts against amyloid-beta peptide-induced toxicity in human neuroblastoma SH-SY5Y cells. PLoS ONE. 2019;14(2): e0212089. https://doi: 10.1371/journal.pone.0212089.

[33]. Baptista FI, Henriques AG, Silva AMS, Wiltfang J, da Cruz e Silva OAB. Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer’s disease. ACS Chem Neurosci. 2014;5:83–92.


  • There are currently no refbacks.

Copyright (c) 2020 Ella Fils Armand;Manjula Shantaram; Simon Ngamli Fewou; Frédéric Nico Njayou; Sayali Chandrashekhar Deolankar;Prashant Kumar Modi; Paul Fewou Moundipa

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

                AR Journals

18K, Street 1st, Gaytri Vihar, Pinto Park, Gwalior, M.P. India

     (Design) 2009-2021


Follow @arjournals on Twitter